FRACASSI, Elena
 Distribuzione geografica
Continente #
EU - Europa 3.381
NA - Nord America 2.768
AS - Asia 2.054
SA - Sud America 364
AF - Africa 54
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.629
Nazione #
US - Stati Uniti d'America 2.709
RU - Federazione Russa 1.299
GB - Regno Unito 878
SG - Singapore 853
CN - Cina 638
BR - Brasile 297
IT - Italia 241
SE - Svezia 213
DE - Germania 179
HK - Hong Kong 172
FR - Francia 144
FI - Finlandia 143
IE - Irlanda 143
VN - Vietnam 108
TR - Turchia 62
KR - Corea 52
JP - Giappone 46
UA - Ucraina 38
IN - India 31
CA - Canada 30
AR - Argentina 23
BD - Bangladesh 18
AT - Austria 17
MX - Messico 17
NL - Olanda 16
BE - Belgio 15
EC - Ecuador 15
ZA - Sudafrica 15
IQ - Iraq 14
ES - Italia 13
NP - Nepal 12
ID - Indonesia 11
BJ - Benin 8
PL - Polonia 8
CO - Colombia 7
EG - Egitto 7
PK - Pakistan 7
CZ - Repubblica Ceca 6
IR - Iran 6
PE - Perù 6
TG - Togo 6
AU - Australia 5
CH - Svizzera 5
GR - Grecia 5
LT - Lituania 5
PY - Paraguay 5
SA - Arabia Saudita 5
VE - Venezuela 5
KE - Kenya 4
BG - Bulgaria 3
BO - Bolivia 3
CL - Cile 3
JM - Giamaica 3
MA - Marocco 3
UZ - Uzbekistan 3
AL - Albania 2
BW - Botswana 2
KW - Kuwait 2
LB - Libano 2
SV - El Salvador 2
TH - Thailandia 2
TN - Tunisia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
CD - Congo 1
CM - Camerun 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
LC - Santa Lucia 1
ML - Mali 1
NZ - Nuova Zelanda 1
PF - Polinesia Francese 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 8.629
Città #
Southend 767
Moscow 455
Singapore 407
Chandler 329
Dallas 314
Jacksonville 287
Ashburn 235
Ann Arbor 174
Hong Kong 170
Dublin 143
Woodbridge 132
Beijing 124
Houston 100
New York 78
Los Angeles 68
Lawrence 54
Princeton 54
Wilmington 53
Verona 50
Jinan 49
The Dalles 44
Tokyo 42
Ho Chi Minh City 41
Munich 39
Nanjing 37
Milan 36
Shenyang 36
Helsinki 31
São Paulo 31
Redmond 30
Redondo Beach 24
Turku 23
Buffalo 22
Hanoi 20
Zhengzhou 20
Columbus 19
London 19
Tianjin 19
Ningbo 18
Haikou 17
Hebei 17
Changsha 16
Brooklyn 15
Brussels 15
Santa Clara 15
Sindelfingen 15
Boardman 14
Falkenstein 14
Fuzhou 14
Taizhou 14
Jiaxing 13
Taiyuan 13
Boston 12
Redwood City 12
Amsterdam 11
Atlanta 11
Johannesburg 11
Nanchang 11
Denver 10
Guangzhou 10
Kathmandu 10
Montreal 10
Rio de Janeiro 10
Seattle 10
Washington 10
Chicago 9
Düsseldorf 9
Hangzhou 9
Lancaster 9
Orani 9
Poplar 9
Ankara 8
Cotonou 8
Jakarta 8
Lappeenranta 8
Phoenix 8
San Francisco 8
Vienna 8
Baghdad 7
Mexico City 7
Norwalk 7
Orem 7
Sanayi 7
Stockholm 7
Belo Horizonte 6
Brasília 6
Cagliari 6
Charlotte 6
Da Nang 6
Detroit 6
Dongguan 6
Frankfurt am Main 6
Izmir 6
Lanzhou 6
Lomé 6
Manchester 6
Porto Alegre 6
Warsaw 6
Brescia 5
Buenos Aires 5
Totale 5.170
Nome #
Artrite Reumatoide e Metabolismo Minerale 243
25-hydroxyvitamin D levels in healthy premenopausal wome: association with bone turnover markers and bone mineral density 224
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 217
Gender differences in clinical features and quality of life of patients with axial spondyloarthritis and psoriatic arthritis 201
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 194
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 189
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 186
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 178
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 164
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 160
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 158
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 150
Artropatie degenerative 147
Calcio e derivati della vitamina D, terapia sostitutiva, calcitonina, fluoruri, bisfosfonati 147
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 146
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 146
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 145
Depression is associated with increased disease activity and higher disability in a large Italian cohort of patients with rheumatoid arthritis 144
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 143
Prevalence of osteoporosis in patients affected by mastocytosis 142
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 141
Coping strategies, emotional distress and perceived disease severity in a cohort of patients with rheumatoid arthritis: a mediation analysis 140
Development and First Validation of a Disease Activity Score for Gout 140
Osteopetrosi 135
Sclerostin and DKK1 in primary hyperparathyroidism. 134
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 134
Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women. 131
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 131
Focal bone involvement in inflammatory arthritis: the role of IL17 130
Prevalence and Factors Associated with Subclinical Left Ventricular Systolic Dysfunction Evaluated by Mid-Wall Mechanics in Rheumatoid Arthritis 125
Vitamina D e artrite reumatoide 121
Osteoporosi 120
Short-term effects on bone turnover markers of a single high dose of oral vitamin D₃. 120
Chronic intravenous aminobisphosphonate therapy increases high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol 119
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 119
Invecchiamento dell'apparato scheletrico 117
Long-term consequences of a treatment course with bisphosphonates in primary hyperparathyroidism 117
Permanent Discontinuation of Glucocorticoids in Polymyalgia Rheumatica is Uncommon but May Be Enhanced by Amino Bisphosphonates 117
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study 116
Previous use of amino-bisphosphonates and circulating gamma/delta T cells 116
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 116
Vitamin D and rheumatic diseases. 113
Long-term effects of neridronate and its discontinuation in patients with primary hyperparathyroidism 112
Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data 108
Clinical and psychological characteristics associated with negative beliefs and concerns about treatment necessity in rheumatic diseases 107
Vitamin D and fractures: a systematic review 107
Neridronic acid for the treatment of bone metabolic diseases 106
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study 106
Comparison and potential determinants of health-related quality of life among rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: A cross-sectional study 105
Changes in bone turnover markers and bone modulators during abatacept treatment 104
The waning of teriparatide effect on bone formation markers in postmenopausal osteoporosis is associated with increasing serum levels of DKK1 104
Osteoporosis Treatment: When to Discontinue and When to Re-start 104
Marked increases in bone mineral density and biochemical markers of bone turnover in patients with anorexia nervosa gaining weight 102
Rational and results of weekly treatment with calcidiol in postmenopausal and senile osteoporosis 100
Depression as a possible determinant of fatigue in patients with axial spondyloarthritis 95
Usefulness of CHA2 DS2 -VASc score to predict mortality and hospitalization in patients with inflammatory arthritis 88
Risk factors for hip fracture in elderly persons 86
The volumetric bone density and cortical thickness in adult patients affected by osteogenesis imperfecta. 84
Efficacy and safety of digital nerve block for pain management during sharp debridement of digital ulcers in systemic sclerosis: A prospective observational study 83
Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture. 83
Risk factors for hip fracture in elderly persons 81
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis? 78
Rational and results of weekly treatment with calcidiol in postmenopausal and senile osteoporosis,Razionale e risultati del trattamento settimanale con calcifediolo nell'osteoporosi postmenopausale e senile 78
Treatment with secukinumab in multi-comorbid patients with psoriatic arthritis 77
Gender differences in psychological features and determinates of quality of life in axial spondyloarthritis and psoriatic arthritis: a cross-sectional study 72
Pharmacodynamics of Oral Cholecalciferol in Healthy Individuals with Vitamin D Deficiency: A Randomized Open-Label Study 71
Glucocorticoid sparing effect of Janus Kinase inhibitors compared to biological Disease Modifying Anti-Rheumatic Drugs in rheumatoid arthritis, a single-center retrospective analysis 71
Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis 68
Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis 67
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort 62
Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement 53
Perforating dermatosis in a young female patient receiving adalimumab biosimilar CTP-17 for chronic plaque psoriasis: A case report 6
Totale 8.744
Categoria #
all - tutte 29.776
article - articoli 27.171
book - libri 0
conference - conferenze 587
curatela - curatele 0
other - altro 384
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.634
Totale 59.552


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021207 0 0 0 0 0 51 9 40 28 5 47 27
2021/2022459 23 147 12 13 27 19 7 23 44 7 38 99
2022/2023998 70 107 84 177 54 244 11 68 122 17 33 11
2023/2024539 23 30 43 53 70 94 23 65 7 14 75 42
2024/20251.499 71 79 73 223 79 60 90 66 223 133 129 273
2025/20263.004 306 256 321 828 1.104 189 0 0 0 0 0 0
Totale 8.744